Oji Yusuke

オジユウスケ | Oji Yusuke

Affiliation and department：
Homepage URL (1)： http://sahswww.med.osaka-u.ac.jp/%7Ehmtonc/index.html

Research field (2)： Hematology and oncology , Pathobiochemistry

Research keywords (7)： WT1 , 検査学 , 腫瘍免疫学 , cancer immunotherapy , cancer biology , 血液内科学 , Hematology

Research theme for competitive and other funds (5)：

新規癌抗原の探索
WTI遺伝子のがん遺伝子様機能
WTI遺伝子の癌発症における役割
Involvement of WTI gene in tuwor cell growth
WTI gene in leukemogenesis

Papers (162)：

森本創世子, 藤木文博, 西田純幸, 永田暁教, 中田潤, 中島博子, 尾路祐介, 岡芳弘, 杉山治夫. GEM併用WT1ワクチン投与膵癌患者からのWT1^126特異的high avidity TCRの単離. 日本臨床免疫学会総会プログラム・抄録集. 2023. 51回. 121-121
Fumihiro Fujiki, Soyoko Morimoto, Yuya Nishida, Satoe Tanii, Nao Aoyama, Miki Inatome, Kento Inoue, Akiko Katsuhara, Hiroko Nakajima, Jun Nakata, et al. Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs. Cancer immunology, immunotherapy : CII. 2023. 72. 7. 2347-2356
Yusuke Oji, Naoki Kagawa, Hideyuki Arita, Norifumi Naka, Ken-Ichiro Hamada, Hidetatsu Outani, Yasushi Shintani, Yoshito Takeda, Eiichi Morii, Kenzo Shimazu, et al. WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1. Cancers. 2023. 15. 2. 393-393
Masaaki Ito, Yusuke Oji, Mayuko Adachi, Rin Imanishi, Shouq Alzaaqi, Takaki Hiwasa, Yoko Oshima, Satoshi Yajima, Takashi Suzuki, Tatsuki Nanami, et al. Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer. Molecular and clinical oncology. 2022. 16. 3. 74-74
Kana Hasegawa, Shunya Ikeda, Moto Yaga, Kouki Watanabe, Rika Urakawa, Akie Iehara, Mai Iwai, Seishin Hashiguchi, Soyoko Morimoto, Fumihiro Fujiki, et al. Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain. Science translational medicine. 2022. 14. 632. eaax7706

ｍore...

MISC (148)：

香川尚己, 尾路祐介, 平山龍一, 木嶋教行, 岡芳弘, 杉山治夫, 貴島晴彦. Long-term outcome of a cocktail Wilms’ tumor 1 (WT1) vaccination using two HLA class I peptides and one class II peptide against recurrent malignant gliomas. 日本脳腫瘍学会学術集会プログラム・抄録集. 2023. 41st
Mizuki Kanegae, Naoki Kagawa, Noriyuki Kijima, Ryuichi Hirayama, Haruka Shimokado, Sumiyuki Nishida, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama, et al. Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy. CANCER SCIENCE. 2022. 113. 524-524
鐘ヶ江瑞稀, 池島彩香, 香川尚己, 木嶋教行, 平山龍一, 下門遥, 西田純幸, 保仙直毅, 坪井昭博, 岡芳弘, et al. 悪性神経膠腫に対するWT1ペプチドワクチン免疫療法WT1 Trioの免疫モニタリング. 日本癌学会総会記事. 2021. 80回. [P12-6]
アルザキ・ショーク, 王谷英達, 鐘ヶ江瑞稀, 下門遥, 西田純幸, 保仙直毅, 坪井昭博, 岡芳弘, 杉山治夫, 尾路祐介. WT1-235ペプチドワクチンを施行された肉腫患者におけるWT1-235 IgMおよびIgG抗体. 日本癌学会総会記事. 2021. 80回. [P12-6]
橋井佳子, 岡芳弘, 坂田尚己, 渡辺新, 尾路祐介, 保仙直毅, 山本紘司, 服部聡, 中島博子, 中田潤, et al. WT1-targeteing immunotherapy after allogeneic HSCT in children with refractory acute leukemias(和訳中). 日本血液学会学術集会. 2021. 83回. OS1-5

ｍore...

Professional career (1)：

医学博士 (大阪大学)

Work history (1)：

- 現在 Osaka University Graduate School of Medicine

Association Membership(s) (10)：

2014年1月日本がん免疫学会・評議員 , 2012年8月血液疾患免疫療法学会・評議員 , 2012年4月日本血液学会・代議員 , 2005年12月近畿血液学地方会・評議員 , 2004年3月 International WT1 Conference・Organizing committee member , THE JAPANESE SOCIETY OF HEMATOLOGY , THE JAPANESE CANCER ASSOCIATION , International Conference on WT1 in Human Neoplasia , SIHDS , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page